UCB, Brussels, Belgium (www.ucb.com) is a global biopharmaceutical company focused on the discovery and development of innovative medicines and solutions to transform the lives of people living with severe diseases of the immune system or of the central nervous system. With 9,000 people in approximately 40 countries, the company generated revenue of EUR 3.4 billion in 2012. UCB is listed on Euronext Brussels (symbol: UCB).
About UCB Research Collaborations
UCB has adopted an open innovation model in which internal and external experts collaborate to address unmet needs for people living with severe diseases of the immune system and the central nervous system. As part of its commitment to raising the standard of care for patients, UCB is building these long-term collaborations and super networks with leading researchers and institutions to use cutting-edge scientific research and technology to deliver unique patient solutions.
About Emory The Robert W. Woodruff Health Sciences Center of Emory University is an academic health sciences center focused on missions of teaching, research, health care, and public service. Its components include Emory University School of Medicine, Nell Hodgson Woodruff School of Nursing, and Rollins School of Public Health; Yerkes National Primate Research Center; Winship Cancer Institute; and Emory Healthcare, the largest, most comprehensive health system in Georgia. The Woodruff Health Sciences Center has $2.8 billion in operating expenditures, 22,356 employees (including 2,681 faculty), 1,550 affiliated faculty, 5,072 students and trainees, and a $5.5 billion economic impact on metro Atlanta.
Forward looking statements This press release contains forward-looking statements bas
Copyright©2012 PR Newswire.
All rights reserved